- Home
- ITRG vs ARCT Comparison
ITRG vs ARCT Comparison
Compare ITRG & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ITRG | ARCT |
|---|---|---|
| Founded | 1997 | 2013 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 482.5M | 526.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ITRG | ARCT |
|---|---|---|
| Price | $3.50 | $6.76 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 11 |
| Target Price | $4.00 | ★ $38.67 |
| AVG Volume (30 Days) | ★ 2.2M | 983.0K |
| Earning Date | 11-12-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.08 | N/A |
| Revenue | ★ $219,125,000.00 | $97,601,000.00 |
| Revenue This Year | $709.65 | N/A |
| Revenue Next Year | $36.86 | $26.81 |
| P/E Ratio | $45.52 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.79 | $5.85 |
| 52 Week High | $3.52 | $24.17 |
Technical Indicators
Market Signals| Indicator | ITRG | ARCT |
|---|---|---|
| Relative Strength Index (RSI) | 66.21 | 30.94 |
| Support Level | $2.73 | $5.85 |
| Resistance Level | $3.12 | $6.49 |
| Average True Range (ATR) | 0.23 | 0.47 |
| MACD | 0.05 | 0.32 |
| Stochastic Oscillator | 96.83 | 26.16 |
Price Performance
Historical ComparisonAbout ITRG Integra Resources Corp.
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.